Company intelligence / Profile preview

McGuff Pharmaceuticals

Santa Ana, California, United Statesmcguffpharmaceuticals.com ↗

Ownership: Private
Development stage: Commercial

Overview

McGuff Pharmaceuticals has achieved FDA approval for several sterile injectable products including ASCOR® (ascorbic acid injection) and hydroxyprogesterone caproate injection. The company operates a state-of-the-art cGMP facility supporting both commercial manufacturing and clinical trial supply. Its 503B outsourcing facility division has developed compounded formulations currently in stability studies but not yet commercially launched[3][6][8].

Therapeutic areas: Women's HealthMetabolic Disorders
Modalities: Small moleculeBiologicInjectable drug productsCompounded drugs
Industry: Biotech

Drug pipeline

2 assets

C-vimin

1 more asset in the full pipeline.

Partnerships

Academic collaborations with UCLA, UCI, Long Beach Memorial Medical Center on clinical trials[4]

Beyond the preview

Go deeper on McGuff Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on McGuff Pharmaceuticals.